142 related articles for article (PubMed ID: 16081345)
21. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
22. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional alterations in the left ventricle of three hypertensive rat models.
Cerutti C; Kurdi M; Bricca G; Hodroj W; Paultre C; Randon J; Gustin MP
Physiol Genomics; 2006 Nov; 27(3):295-308. PubMed ID: 16882881
[TBL] [Abstract][Full Text] [Related]
24. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
26. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies.
Gallego-Delgado J; Lazaro A; Osende JI; Esteban V; Barderas MG; Gomez-Guerrero C; Vega R; Vivanco F; Egido J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S159-64. PubMed ID: 17130255
[TBL] [Abstract][Full Text] [Related]
28. Electrocardiography-left ventricular mass discrepancies in left ventricular hypertrophy: electrocardiography imperfection or beyond perfection?
Bacharova L
J Electrocardiol; 2009; 42(6):593-6. PubMed ID: 19608195
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular mass by 12-lead electrocardiogram in healthy subjects: comparison to cardiac magnetic resonance imaging.
Carlsson MB; Trägårdh E; Engblom H; Hedström E; Wagner G; Pahlm O; Arheden H
J Electrocardiol; 2006 Jan; 39(1):67-72. PubMed ID: 16387055
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular hypertrophy in patients with autonomic failure.
Maule S; Milan A; Grosso T; Veglio F
Am J Hypertens; 2006 Oct; 19(10):1049-54. PubMed ID: 17027826
[TBL] [Abstract][Full Text] [Related]
31. The effect of reduced intercellular coupling on electrocardiographic signs of left ventricular hypertrophy.
Bacharova L; Mateasik A; Krause R; Prinzen FW; Auricchio A; Potse M
J Electrocardiol; 2011; 44(5):571-6. PubMed ID: 21757205
[TBL] [Abstract][Full Text] [Related]
32. Association between wasted pressure effort and left ventricular hypertrophy in hypertension: influence of arterial wave reflection.
Hashimoto J; Nichols WW; O'Rourke MF; Imai Y
Am J Hypertens; 2008 Mar; 21(3):329-33. PubMed ID: 18202668
[TBL] [Abstract][Full Text] [Related]
33. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular hypertrophy: disagreements between increased left ventricular mass and ECG-LVH criteria: the effect of impaired electrical properties of myocardium.
Bacharova L
J Electrocardiol; 2014; 47(5):625-9. PubMed ID: 24973139
[TBL] [Abstract][Full Text] [Related]
35. Prolonged recovery time in the left precordial leads reflects increased left ventricular mass in the hypertensive patients.
Hara H; Niwano S; Ikeda N; Izumi T
J Electrocardiol; 2005 Oct; 38(4):406-11. PubMed ID: 16216619
[TBL] [Abstract][Full Text] [Related]
36. Changes in plasma prekallikrein activity, blood pressure, and left ventricular thickness in hypertensive and normotensive diabetic rats.
Sharma JN; Kesavarao U
Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):75-8. PubMed ID: 17440623
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of alpha-enolase in the normal and pathological cardiac growth.
Zhu LA; Fang NY; Gao PJ; Jin X; Wang HY
Exp Mol Pathol; 2009 Aug; 87(1):27-31. PubMed ID: 19450578
[TBL] [Abstract][Full Text] [Related]
38. Electrocardiographic diagnosis of left ventricular hypertrophy: depolarization changes.
Bacharova L; Estes EH
J Electrocardiol; 2009; 42(3):228-32. PubMed ID: 19398051
[TBL] [Abstract][Full Text] [Related]
39. Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies.
Gallego-Delgado J; Connolly SB; Lázaro A; Sadlier D; Kieran NE; Sugrue DD; Doran P; Brady HR; Osende J; Egido J
Hypertens Res; 2009 May; 32(5):347-57. PubMed ID: 19325563
[TBL] [Abstract][Full Text] [Related]
40. Enhanced acidotic myocardial Ca2+ responsiveness with training in hypertension.
Renna BF; Kubo H; MacDonnell SM; Crabbe DL; Reger PO; Houser SR; Libonati JR
Med Sci Sports Exerc; 2006 May; 38(5):847-55. PubMed ID: 16672836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
